Chimerix Inc

-0.02 (-1.37%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)158.05M
Current PE1.03
Forward PE 0.92
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.58 Million
Adjusted EPS-$0.24
See more estimates
10-Day MA$1.82
50-Day MA$1.94
200-Day MA$2.20
See more pivots

Chimerix Inc Stock, NASDAQ:CMRX

2505 Meridian Parkway, Suite 100, Durham, North Carolina 27713
United States of America
Phone: +1.919.806.1074
Number of Employees: 87


Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.